Carbylan Therapeutics Inc Stock
Carbylan Therapeutics Inc shows a slight decrease today, losing €0.000 (-0.950%) compared to yesterday.
The community is currently still undecided about Carbylan Therapeutics Inc with 1 Buy predictions and 1 Sell predictions.
Based on the current price of 10.4 € the target price of 22 € shows a potential of 111.54% for Carbylan Therapeutics Inc which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Carbylan Therapeutics Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Carbylan Therapeutics Inc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carbylan Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Carbylan Therapeutics Inc | -0.950% | -2.703% | -3.571% | 10.204% | 0.000% | -50.909% | -49.462% |
| Syros Pharmaceuticals Inc. | -2.420% | -5.743% | -1.245% | 26.596% | -27.879% | -89.561% | - |
| Clinuvel Pharmaceuticals | 2.660% | 1.844% | 5.446% | -19.365% | -4.125% | -50.212% | -52.141% |
| Pharma Mar S.A. | -2.290% | -0.831% | 34.485% | -0.167% | -14.107% | -57.432% | - |